Robbins Farley Sells 61 Shares of HCA Healthcare, Inc. $HCA

Robbins Farley lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.0% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 5,866 shares of the company’s stock after selling 61 shares during the quarter. Robbins Farley’s holdings in HCA Healthcare were worth $2,247,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of HCA. Nuveen LLC bought a new stake in shares of HCA Healthcare during the first quarter valued at approximately $569,217,000. Pacer Advisors Inc. grew its holdings in shares of HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after purchasing an additional 1,329,618 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after purchasing an additional 587,036 shares in the last quarter. Finally, Abdiel Capital Advisors LP purchased a new position in shares of HCA Healthcare in the first quarter valued at $164,835,000. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on HCA. Robert W. Baird lifted their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Barclays lifted their price objective on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research note on Thursday, September 18th. JPMorgan Chase & Co. boosted their target price on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Stephens raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Finally, Royal Bank Of Canada lowered their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a research note on Monday, July 28th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $407.75.

HCA Healthcare Stock Up 0.5%

NYSE:HCA opened at $421.07 on Tuesday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $422.96. The company has a 50-day moving average of $390.93 and a 200 day moving average of $370.25. The firm has a market cap of $98.53 billion, a PE ratio of 17.70, a price-to-earnings-growth ratio of 1.32 and a beta of 1.41. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period in the prior year, the firm earned $5.50 earnings per share. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s payout ratio is currently 12.11%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.